rxstat › Shortages › Fluvastatin
Fluvastatin shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Fluvastatin products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 31, 2026.
In shortage since
Jun 3, 2026
Est. full return
Aug 31, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · since Jun 3, 2026, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Sep 18, 2024 · Disruption of the manufacture of the drug.
ResolvedTEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Apr 24, 2024 · Disruption of the manufacture of the drug.
ResolvedTEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Jan 10, 2024 · Disruption of the manufacture of the drug.
ResolvedTEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Jul 4, 2023 · Disruption of the manufacture of the drug.
ResolvedTEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
ResolvedTEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Dec 14, 2021 · Demand increase for the drug.
ResolvedTEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Apr 28, 2021 · Disruption of the manufacture of the drug.
ResolvedTEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Mar 24, 2021 · Disruption of the manufacture of the drug.
ResolvedTEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Jun 3, 2020 · Disruption of the manufacture of the drug.
DiscontinuedLESCOL XL
80MG · TABLET (EXTENDED-RELEASE) · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02250527
ResolvedTEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Apr 1, 2020 · Disruption of the manufacture of the drug.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
Fluvastatin is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Fluvastatin is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AA).
Recent changes
Common questions
When will Fluvastatin be back in stock in Canada?
The latest manufacturer estimate is Aug 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Fluvastatin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.